Eli Lilly Raised Its Outlook. Is the Stock a Buy Now? - The Motley Fool
The anti-obesity medication stock is way up, and there could be more fuel in the tank.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 1.0, copyright 2016 - 2024
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments